Skip to the page

Data / Form D filings / Renova Therapeutics, Inc.

Renova Therapeutics, Inc.: Form D filing

Renova Therapeutics, Inc., a biotechnology company in Carlsbad, CA, filed a Form D with the SEC in 2024. The latest, on September 9, 2024, reports $166,500 sold of a $500,000 offering to 7 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
701 PALOMAR AIRPORT ROAD, SUITE 300, Carlsbad, CA, 92011
Phone
(858) 461-1837
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2036392

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 9, 2024New notice$500,000$166,500$333,5007Jul 23, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Roy CosanDirector
Pierre LecocqDirector
Vijay MahantDirector
Michael TorresDirector
Kirk HammondDirector
William DavidsonDirector
Morgan XuDirector
Shawn SwaneyExecutive Officer

Other biotechnology companies in California that filed recently

Every Form D from the week of Sep 9, 2024 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Renova Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.